H.R. 2870 · 117th Congress · House

Essential Medicines Strategic Stockpile Act of 2021

Active· Referred to the Subcommittee on Health.
Introduced
Apr 28, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Essential Medicines Strategic Stockpile Act of 2021

This bill requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage.

Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs.

The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.

Action Timeline

4
  1. APR 29, 2021Committee

    Referred to the Subcommittee on Health.

  2. APR 28, 2021IntroReferral

    Introduced in House

  3. APR 28, 2021IntroReferral

    Introduced in House

  4. APR 28, 2021IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: Apr 29, 2021

Active

Energy and Commerce Committee

hsif00

Referred: Apr 28, 2021

Active